SPECTRAL AI INC
MDAINASDAQTrading Snapshot
- Day Range
- $1.56 – $1.59
- 52-Week Range
- $1.18 – $2.97
- Volume
- $2.32B
- Avg Volume
- $2.14B
- Shares Outstanding
- 31.8M
- Next Earnings
- Oct 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $20M
- Last Q Revenue
- $4M
- P/E Ratio
- -4.5
- P/S Ratio
- 3.3x
- EPS (TTM)
- $-0.33
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +61.6%
Why Investors Own MDAI
- ✓High-growth profile — revenue up +48.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 36% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SPECTRAL AI INC
MDAI
StockOtter · stockotter.spaceAbout SPECTRAL AI INC
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds
DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decis
Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript
Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript
Spectral AI Q2 Earnings Call Highlights
Spectral AI NASDAQ: MDAI said its second-quarter results marked a transition toward commercial operations following the U.S. Food and Drug Administration's De Novo clearance of its DeepView System for burn assessment in
Spectral AI Announces 2026 Second Quarter Financial Results
Company Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication Strong Cash Position of $14.0 Million at June 30, 2026 DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (